ArticlePsychopharmacology2026
Discriminative stimulus, rewarding, and reinforcing effects of 4-Fluoroethylphenidate in rodents.
Article in Psychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
rationale4-Fluoroethylphenidate (4 F-EPH) is a novel synthetic psychostimulant structurally similar to ethylphenidate, recently detected in illicit drug markets. Its abuse liability remains unclear.
objectivesThis study aimed to evaluate the abuse-related behavioral effects of 4 F-EPH in rodents using various preclinical models.
methodsDrug discrimination tests were conducted in male Sprague-Dawley rats trained to differentiate methamphetamine (METH, 0.5 mg/kg) or cocaine (5.6 mg/kg) from saline, and 4 F-EPH was subsequently tested for substitution at doses of 1, 2, and 5 mg/kg (i.p.) to assess its interoceptive similarity. Reward potential was assessed in C57BL/6J mice via the conditioned place preference (CPP) test at 1, 10, and 40 mg/kg. Locomotor activity was measured for 60 min after 4 F-EPH administration (0.01, 0.1, 1, 10 and 40 mg/kg). Intravenous self-administration (SA) was used to examine reinforcing effects under a fixed-ratio 1 and 2 schedule with 1 or 4 mg/kg/infusion.
results4 F-EPH fully substituted for METH and cocaine with ED₅₀ values of 1.655 mg/kg and 2.043 mg/kg, respectively. In CPP, significant place preference was seen at 10 and 40 mg/kg. Locomotor activity increased dose-dependently, peaking at 10 mg/kg. Mice reliably self-administered 1 mg/kg of 4 F-EPH; however, the 4 mg/kg dose reduced intake, possibly due to aversive or rate-limiting effects.
conclusions4 F-EPH displays strong METH- and cocaine-like interoceptive effects, rewarding potential, and reinforcing properties, indicating a high abuse potential. Further toxicological evaluation is warranted.
Indexed as
Identifiers
41925822What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.